share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

Altimmune | 4:持股变动声明-高管 Roberts M Scot
美股SEC公告 ·  08/01 17:46
Moomoo AI 已提取核心信息
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
2024年7月31日,Altimmune公司的首席科学官万·斯科特·罗伯茨以每股5.41美元的价格购买了650股普通股。此次交易后,罗伯茨直接持有该公司的总股数为43,310股。此外,还披露了罗伯茨配偶持有15股的间接所有权。这笔交易属于非衍生证券的直接持股,反映了公司重要高管对公司业绩的利益。
2024年7月31日,Altimmune公司的首席科学官万·斯科特·罗伯茨以每股5.41美元的价格购买了650股普通股。此次交易后,罗伯茨直接持有该公司的总股数为43,310股。此外,还披露了罗伯茨配偶持有15股的间接所有权。这笔交易属于非衍生证券的直接持股,反映了公司重要高管对公司业绩的利益。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息